Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-3-24
pubmed:abstractText
Cancer colonization of bone leads to the activation of osteoclasts, thereby producing local tissue acidosis and bone resorption. This process may contribute to the generation of both ongoing and movement-evoked pain, resulting from the activation of sensory neurons that detect noxious stimuli (nociceptors). The capsaicin receptor TRPV1 (transient receptor potential vanilloid subtype 1) is a cation channel expressed by nociceptors that detects multiple pain-producing stimuli, including noxious heat and extracellular protons, raising the possibility that it is an important mediator of bone cancer pain via its capacity to detect osteoclast- and tumor-mediated tissue acidosis. Here, we show that TRPV1 is present on sensory neuron fibers that innervate the mouse femur and that, in an in vivo model of bone cancer pain, acute or chronic administration of a TRPV1 antagonist or disruption of the TRPV1 gene results in a significant attenuation of both ongoing and movement-evoked nocifensive behaviors. Administration of the antagonist had similar efficacy in reducing early, moderate, and severe pain-related responses, suggesting that TRPV1 may be a novel target for pharmacological treatment of chronic pain states associated with bone cancer metastasis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
23
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3126-31
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15788769-Activating Transcription Factor 3, pubmed-meshheading:15788769-Analgesics, pubmed-meshheading:15788769-Analysis of Variance, pubmed-meshheading:15788769-Animals, pubmed-meshheading:15788769-Behavior, Animal, pubmed-meshheading:15788769-Bone Neoplasms, pubmed-meshheading:15788769-Bone and Bones, pubmed-meshheading:15788769-Disease Models, Animal, pubmed-meshheading:15788769-Disease Progression, pubmed-meshheading:15788769-Drug Administration Schedule, pubmed-meshheading:15788769-Functional Laterality, pubmed-meshheading:15788769-Ganglia, Spinal, pubmed-meshheading:15788769-Gene Expression Regulation, Neoplastic, pubmed-meshheading:15788769-Immunohistochemistry, pubmed-meshheading:15788769-Male, pubmed-meshheading:15788769-Mice, pubmed-meshheading:15788769-Mice, Inbred C57BL, pubmed-meshheading:15788769-Mice, Transgenic, pubmed-meshheading:15788769-Nerve Fibers, pubmed-meshheading:15788769-Pain, pubmed-meshheading:15788769-Pain Measurement, pubmed-meshheading:15788769-TRPV Cation Channels
pubmed:year
2005
pubmed:articleTitle
Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain.
pubmed:affiliation
Neurosystems Center and Department of Preventive Sciences, University of Minnesota, Minneapolis, Minnesota 55455, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural